Rare Primary Malignant Bone Sarcomas.

Area of Science:

• Oncology
• Orthopedic Surgery
• Pathology

Background:

• Rare primary malignant bone sarcomas (RPMBS) constitute 5-10% of bone tumors, posing diagnostic challenges.
• These include spindle cell, round cell, hemangiopericytoma-like, vascular tumors, and soft tissue histotypes like myxofibrosarcoma in bone.
• Systemic therapy for these rare bone sarcomas remains controversial.

Purpose of the Study:

• To review the relevance, clinical aspects, diagnostic procedures, and staging of RPMBS.
• To provide treatment recommendations and discuss current research for these rare bone tumors.
• To consolidate information on a composite group of ultra-rare bone sarcomas.

Main Methods:

• Literature review of rare primary malignant bone sarcomas.
• Analysis of diagnostic challenges and treatment strategies.
• Synthesis of current research and clinical recommendations.

Main Results:

• RPMBS present diagnostic difficulties and include diverse histotypes.
• Surgical resection is standard; systemic therapy approaches vary based on tumor type (e.g., osteosarcoma-like chemotherapy for spindle cell, Ewing sarcoma regimens for round cell).
• Limited studies exist on the analogies and differences among these ultra-rare bone tumors.

Conclusions:

• RPMBS require specialized diagnostic and treatment approaches.
• Further research is needed to clarify optimal systemic therapies for these rare bone malignancies.
• This review consolidates current knowledge to aid clinicians and researchers in managing RPMBS.